Prices delayed ≤15 min
AI Analysis Summary
Colgate-Palmolive Company at a Glance: What the Business Does Colgate-Palmolive Company (CL) is a leading player in the consumer defensive sector, particularly within the Household & Personal Products industry. The company, headquartered in New York City, has a diverse portfolio that includes toothpaste, toothbrushes, mouthwash, and a variety of personal care products such as shampoos, conditioners, and soaps. Additionally, Colgate-Palmolive has a segment dedicated to pet nutrition, which adds another layer of revenue diversity. With a workforce of approximately 34,000 employees, the company operates globally, leveraging its strong brand recognition and customer loyalty to maintain a competitive edge. Its unique positioning in the market is bolstered by a reputation for quality and innovation, which helps it navigate competitive pressures effectively. Breaking Down CL's Financials: Revenue, Margins & EPS Colgate-Palmolive's financial performance shows a steady upward trajectory in revenue, with the latest figures indicating $20.38 billion in 2025, up from $20.10 billion in 2024. This represents a year-over-year growth rate of 1.4%. However, it's worth noting that the company has faced challenges in profitability, as evidenced by a net income decline of 26.2%, bringing it down to $2.13 billion. The gross profit stands robust at $12.25 billion, translating into a gross margin of 60.1%. Operating income is reported at $3.31 billion, yielding an operating margin of 16.2%. Although earnings per share (EPS) have also dipped to $2.63, these figures underscore the mixed financial landscape Colgate-Palmolive currently navigates. CL Balance Sheet Check: Debt, Cash & Liquidity When evaluating Colgate-Palmolive's balance sheet, the company appears to be in a precarious position regarding its debt levels. With total liabilities of $15.96 billion against total assets of $16.33 billion, the company has a thin margin of safety. The debt-to-equity ratio is notably high at 147.89, indicating a heavy reliance on debt financing. Total debt stands at $7.99 billion, while cash reserves are relatively modest at $1.29 billion, leading to a net debt position of $6.70 billion. Additionally, the current ratio of 0.83 suggests that the company may face challenges in covering its short-term liabilities, raising concerns about its liquidity and overall financial health. Where Does CL's Cash Go? A Capital Allocation Review Colgate-Palmolive's operating cash flow for the latest year is a healthy $4.20 billion, which indicates solid cash generation from core operations. The company has also reported free cash flow of $3.63 billion, reflecting a growth rate of 2.5% year-over-year. This positive cash flow is critical as it provides flexibility in capital allocation. However, the company has engaged in stock buybacks totaling $1.21 billion, which raises questions about its priorities in deploying capital. The absence of dividend payments may signal a focus on reinvesting in growth opportunities or managing debt, but it could also deter income-seeking investors. Overall, while free cash flow is growing, the strategic allocation of capital remains a focal point for stakeholders. CL Valuation: Expensive, Cheap, or Fairly Priced? Analyzing Colgate-Palmolive's valuation metrics reveals a mixed picture. The current price-to-earnings (P/E) ratio stands at 33.56, which is significantly above the industry average, suggesting that investors are pricing in strong growth expectations. The price-to-book ratio is extremely high at 1303.08, indicating that the market values the company at a premium relative to its equity. Additionally, the price-to-sales ratio of 3.45 and an EV/EBITDA ratio of 19.58 further suggest that the stock may be overvalued compared to its peers. These elevated valuation ratios imply that investors are betting on future growth, but they also raise the risk of correction if the company fails to meet these expectations. Catalysts Ahead: CL's Growth Outlook & Analyst Estimates While there are no specific analyst estimates available for Colgate-Palmolive, the company's growth outlook hinges on several key factors. The firm has opportunities for market expansion, particularly in emerging markets where consumer demand for personal care products continues to rise. Innovations in product offerings, especially in oral and pet care segments, could drive further revenue growth. However, the company's ability to rebound from recent declines in net income and EPS will be critical in determining its future market position. Investors should keep an eye on consumer trends and how effectively Colgate-Palmolive can leverage its brand equity to capture growth in a competitive landscape. CL Investment Risks Worth Knowing About Investing in Colgate-Palmolive does come with its share of risks. The company's high debt burden, reflected in its debt-to-equity ratio of 147.89, poses a significant risk, particularly if interest rates rise or if the market experiences downturns. Additionally, margin compression could be a concern as raw material costs fluctuate, impacting profitability. Competitive threats from both established and emerging brands in the personal care market also present challenges. Regulatory risks, particularly concerning environmental standards and product safety, are additional factors that could affect operations. Given its low beta of 0.30, the stock is less volatile than the broader market, but that does not completely shield it from macroeconomic sensitivities. 2026 Outlook: Is Colgate-Palmolive Company Stock Worth Owning? In conclusion, Colgate-Palmolive Company (CL) presents a complex investment case as we look toward 2026. The company's strong brand presence and diversified product offerings provide a solid foundation for growth, but significant challenges lie ahead, particularly regarding its financial health and competitive positioning. With high valuation ratios suggesting a premium price, investors must weigh the potential for growth against the backdrop of increasing risks. This stock may appeal to growth-oriented investors willing to accept volatility for the chance of future returns, while value-focused investors might find the current pricing concerning. Keeping an eye on operational performance, cash flow sustainability, and market conditions will be crucial for anyone considering an investment in Colgate-Palmolive.
Financial figures come from Colgate-Palmolive Company's latest annual SEC filing (fiscal year 2025), so they can lag recent quarters. Prices are delayed up to 15 minutes.
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline,
Frequently Asked Questions about CL
Colgate-Palmolive Company (CL): what does the company actually do?
Colgate-Palmolive Company specializes in manufacturing and selling consumer products globally, with a focus on oral, personal, and home care items. Their offerings include well-known products like toothpaste, toothbrushes, and mouthwash, as well as pet nutrition. This diverse portfolio positions them strongly in the household and personal products industry.
Is CL worth adding to a portfolio in 2026?
Evaluating Colgate-Palmolive's current P/E ratio of 33.56 alongside its revenue growth of 1.4% suggests a mixed outlook. While the company has a stable market presence, the growth rate indicates that significant appreciation may be limited in the near term. Investors might want to consider these factors alongside broader market conditions before making a decision.
What are Colgate-Palmolive Company's market cap and current trading price?
Currently, Colgate-Palmolive is trading at $88.27, giving it a market capitalization of approximately $70.37 billion. This places the stock within a healthy range, especially when considering its 52-week high of $99.33 and low of $74.55, indicating some volatility but also room for potential growth.
Is CL a dividend-paying stock?
Colgate-Palmolive does not distribute dividends to its shareholders, which may lead some income-focused investors to look elsewhere. Instead, the company appears to reinvest its earnings for growth, as evidenced by its impressive free cash flow of $3.63 billion.
How does Colgate-Palmolive Company stack up on profitability?
Colgate-Palmolive exhibits strong profitability metrics, boasting a net income of $2.13 billion and a net margin of 10.5%. Additionally, its return on equity (ROE) stands at an extraordinary 3948.1%, reflecting the company's efficiency in generating profit relative to shareholders' equity.
Is CL trading at a reasonable P/E multiple?
With a P/E ratio of 33.56, Colgate-Palmolive's valuation is relatively high compared to the broader consumer defensive sector. This suggests that investors are paying a premium for the stock, which may be justified by its established market presence but could also indicate that growth expectations are already priced in.
Is Colgate-Palmolive Company carrying a lot of debt?
Colgate-Palmolive's debt-to-equity ratio stands at 147.89, indicating a significant level of debt relative to its equity. However, the company's free cash flow of $3.63 billion provides a cushion, suggesting that it can manage its debt obligations effectively despite the leverage.
What's the 52-week high and low for CL?
The 52-week high for Colgate-Palmolive is $99.33, while the low is $74.55. Currently priced at $88.27, the stock is positioned in the middle of this range, hinting at potential for both upward movement and risk of decline depending on market conditions.
Does CL behave more like a growth stock or a value stock?
Colgate-Palmolive's revenue growth of 1.4% and an EPS of $2.63 suggest that it leans more towards a value stock rather than a growth stock. The high P/E ratio indicates that investors are willing to pay for stability and consistent performance, rather than aggressive growth prospects.
What's the biggest risk factor for CL investors?
One significant risk for investors in Colgate-Palmolive is its beta of 0.30, which reflects lower volatility but could also signal a lack of responsiveness to market rallies. Additionally, the company's high debt-to-equity ratio presents concerns about financial flexibility, especially in competitive market conditions.